Next Article in Journal
Impact of the Hydration States of Polymers on Their Hemocompatibility for Medical Applications: A Review
Next Article in Special Issue
Aptamers for DNA Damage and Repair
Previous Article in Journal
Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms
Previous Article in Special Issue
Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids
Review

Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes

by 1,2,†, 1,2,†, 1,2,†, 1,2, 1,2,3,*, 1,2,* and 1,2,*
1
Institute of Precision Medicine and Innovative Drug Discovery, School of Chinese Medicine, Hong Kong Baptist University (HKBU), Hong Kong 999077, China
2
Institute for Advancing Translational Medicine in Bone & Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University (HKBU), Hong Kong 999077, China
3
Faculty of Materials Science and Chemical Engineering, the State Key Laboratory Base of Novel Functional Materials and Preparation Science, Ningbo University, Ningbo 315211, Zhejiang, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2017, 18(8), 1683; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18081683
Received: 10 July 2017 / Revised: 27 July 2017 / Accepted: 1 August 2017 / Published: 2 August 2017
(This article belongs to the Special Issue Aptamers)
Nucleic acid aptamers have minimal immunogenicity, high chemical synthesis production, low cost and high chemical stability when compared with antibodies. However, the susceptibility to nuclease degradation, rapid excretion through renal filtration and insufficient binding affinity hindered their development as drug candidates for therapeutic applications. In this review, we will discuss methods to conquer these challenges and highlight recent developments of chemical modifications and technological advances that may enable early aptamers to be translated into clinical therapeutics. View Full-Text
Keywords: nucleic acid aptamer; nuclease degradation; rapid excretion; binding affinity; chemical modification nucleic acid aptamer; nuclease degradation; rapid excretion; binding affinity; chemical modification
Show Figures

Graphical abstract

MDPI and ACS Style

Ni, S.; Yao, H.; Wang, L.; Lu, J.; Jiang, F.; Lu, A.; Zhang, G. Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes. Int. J. Mol. Sci. 2017, 18, 1683. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18081683

AMA Style

Ni S, Yao H, Wang L, Lu J, Jiang F, Lu A, Zhang G. Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes. International Journal of Molecular Sciences. 2017; 18(8):1683. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18081683

Chicago/Turabian Style

Ni, Shuaijian, Houzong Yao, Lili Wang, Jun Lu, Feng Jiang, Aiping Lu, and Ge Zhang. 2017. "Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes" International Journal of Molecular Sciences 18, no. 8: 1683. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18081683

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop